No. |
GO terms |
Targets |
# of targets |
p-value (EPT)↑ |
p-value (EPD) |
1 |
glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity |
NR3C1 |
1 |
0.01 |
0.031 |
2 |
DNA hairpin binding |
NR0B1 |
1 |
0.01 |
0.0084 |
3 |
double-stranded DNA-dependent ATPase activity |
ANXA1 |
1 |
0.012 |
0.0063 |
4 |
glucocorticoid receptor activity |
NR3C1 |
1 |
0.014 |
0.031 |
5 |
steroid hormone receptor binding |
NR0B1 |
1 |
0.016 |
0.0084 |
6 |
AF-2 domain binding |
NR0B1 |
1 |
0.018 |
0.014 |
7 |
annealing helicase activity |
ANXA1 |
1 |
0.02 |
0.0063 |
8 |
phospholipase A2 inhibitor activity |
ANXA1 |
1 |
0.023 |
0.012 |
9 |
arginine binding |
NOS2 |
1 |
0.023 |
0.04 |
10 |
steroid hormone binding |
NR3C1 |
1 |
0.024 |
0.036 |
11 |
NADPH-hemoprotein reductase activity |
NOS2 |
1 |
0.024 |
0.039 |
12 |
nitric-oxide synthase activity |
NOS2 |
1 |
0.025 |
0.041 |
13 |
tetrahydrobiopterin binding |
NOS2 |
1 |
0.025 |
0.039 |
14 |
single-stranded RNA binding |
ANXA1 |
1 |
0.026 |
0.012 |
15 |
protein binding, bridging |
ANXA1 |
1 |
0.027 |
0.012 |
16 |
helicase activity |
ANXA1 |
1 |
0.027 |
0.012 |
17 |
receptor binding |
NOS2;ANXA1 |
2 |
0.027 |
0.12 |
18 |
steroid hormone receptor activity |
NR1I2;NR0B1 |
2 |
0.027 |
0.099 |
19 |
RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding |
NR1I2;NR0B1 |
2 |
0.032 |
0.085 |
20 |
single-stranded DNA binding |
ANXA1 |
1 |
0.033 |
0.012 |
21 |
calcium-dependent phospholipid binding |
ANXA1 |
1 |
0.035 |
0.018 |
22 |
transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
NR1I2 |
1 |
0.035 |
0.05 |
23 |
FMN binding |
NOS2 |
1 |
0.035 |
0.048 |
24 |
steroid binding |
NR3C1 |
1 |
0.061 |
0.071 |
25 |
calcium-dependent protein binding |
ANXA1 |
1 |
0.061 |
0.031 |
26 |
structural molecule activity |
ANXA1 |
1 |
0.063 |
0.032 |
27 |
zinc ion binding |
NR1I2;NR3C1 |
2 |
0.063 |
0.21 |
28 |
protein homodimerization activity |
NOS2;NR0B1 |
2 |
0.064 |
0.16 |
29 |
RNA polymerase II regulatory region sequence-specific DNA binding |
NR1I2 |
1 |
0.064 |
0.048 |
30 |
flavin adenine dinucleotide binding |
NOS2 |
1 |
0.064 |
0.06 |
31 |
sequence-specific DNA binding |
NR0B1 |
1 |
0.064 |
0.062 |
32 |
protein domain specific binding |
NR0B1 |
1 |
0.065 |
0.048 |
33 |
phospholipid binding |
ANXA1 |
1 |
0.065 |
0.047 |
34 |
NADP binding |
NOS2 |
1 |
0.065 |
0.048 |
35 |
transcription corepressor activity |
NR0B1 |
1 |
0.065 |
0.032 |
36 |
RNA polymerase II core promoter proximal region sequence-specific DNA binding |
NR3C1 |
1 |
0.065 |
0.079 |
37 |
transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
NR3C1 |
1 |
0.066 |
0.079 |
38 |
transcription coactivator activity |
NR1I2 |
1 |
0.078 |
0.065 |
39 |
transcription factor binding |
NR0B1 |
1 |
0.11 |
0.081 |
40 |
transcription factor activity, sequence-specific DNA binding |
NR3C1 |
1 |
0.11 |
0.11 |
41 |
heme binding |
NOS2 |
1 |
0.12 |
0.099 |
42 |
drug binding |
NR1I2 |
1 |
0.12 |
0.19 |
43 |
iron ion binding |
NOS2 |
1 |
0.13 |
0.071 |
44 |
RNA binding |
NR0B1 |
1 |
0.14 |
0.032 |
45 |
DNA binding |
NR0B1 |
1 |
0.15 |
0.12 |
46 |
calcium ion binding |
ANXA1 |
1 |
0.25 |
0.12 |